General Infectious Disease
2022 EULAR Recommendations for Infection Prophylaxis in Rheumatic Diseases
- Appropriate Antimicrobial Therapy for Bloodstream Infections Lowers Mortality Risk
- Baseline Resistance to Second-Generation INSTIs, First-Line NRTIs Unlikely in HIV
- MICU Palliative Care Team Improves Quality of Care, Decreases Inpatient Mortality
- Tocilizumab, Sarilumab Associated With Liver Injury Risk in COVID-19 Treatment
- AHA Presents Up-To-Date Statistics for Cardiovascular Disease
- ACP Creates Living Guideline for Interventions During Acute Phase of Major Depression
- Cystatin C-Based Equation Accurate for Estimating Glomerular Filtration Rate
- CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
- Predictors of Hospital-Acquired C difficile Infection in Children With Diarrhea Identified
- FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis
- COVID-19-Related Treatment Delays May Increase Disparities in Cancer Care
- COVID-19 Vaccine Timing After Rituximab Can Decrease Hospitalization in MS
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Crovalimab Is Safe, Effective in Complement Inhibitor-Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria
Delay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
Actemra Approved for Treatment of Hospitalized COVID-19 Patients
Advanced MUP Has Similar Outcomes as Advanced cMKP Despite Poorer Prognosis
Wegovy Gains Approval for Treating Obesity in Adolescents
